Panavance Therapeutics Inc. jobs and careers
Berwyn, United States
About Panavance Therapeutics Inc.
Panavance Therapeutics Inc. is a US, clinical-stage pharmaceutical company established in 2021 by the Swiss-based Avensis Pharma AG, a subsidiary of Ed. Geistlich Söhne AG für Chemische Industrie. Panavance is focused on advancing the development of GP-2250, a novel oncology therapeutic intended to improve outcomes and quality of life for patients with cancer. With its highly capable team and strong academic and industry partnerships, Panavance is pursuing a rigorous program to bring GP-2250 to patients around the world.
- Founded
- 2021
- Employees
- 1 to 10
- Headquarters
- Berwyn
Leadership
The top of Panavance Therapeutics Inc.'s org chart, with how many people report into each leader.
José Iglesias
Chief Medical Officer
4 reports
Ben Steinmetz
Chief Commercial Officer
Tom Hess
Chief Financial Officer
Carol Gorman
Executive Assistant
Robert Hrubiec
Head, Intellectual Property & Patents
Hanns Moehler
Head, Pharmacology
Alexander Smith
Head, CMC & Quality
Duane Sofia
Head, Non-clinical Research
Kathryn Martin
Head, Scientific & Regulatory Communications
Jobs at Panavance Therapeutics Inc.
No open positions right now. Explore more companies on TheJobsMap.